Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis

Allogeneic hematopoietic cell transplantation (allo-HCT) is a curative therapy for relapsed/refractory and high-risk non-Hodgkin lymphoma (NHL). However, no large studies have evaluated allo-HCT utilization in elderly NHL patients (≥65 years). Using the CIBMTR registry, we report a time-trend analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Nirav N., Ahn, Kwang Woo, Litovich, Carlos, Sureda, Anna, Kharfan-Dabaja, Mohamed A., Awan, Farrukh T., Ganguly, Siddhartha, Gergis, Usama, Inwards, David, Karmali, Reem, Lazaryan, Alexsandr, Lekakis, Lazaros, Munshi, Pashna, Nathan, Sunita, Saad, Ayman A., Solh, Melhem, Steinberg, Amir, Vij, Ravi, Wood, William A., Fenske, Timothy S., Smith, Sonali, Hamadani, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890709/
https://www.ncbi.nlm.nih.gov/pubmed/31796726
http://dx.doi.org/10.1038/s41408-019-0261-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890709/
https://www.ncbi.nlm.nih.gov/pubmed/31796726
http://dx.doi.org/10.1038/s41408-019-0261-1

Ejemplares similares